Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 288

1.

[IoNESCO trial: Immune neoajuvant therapy in early stage non-small cell lung cancer].

Mignard X, Antoine M, Moro-Sibilot D, Dayen C, Mennecier B, Gervais R, Amour E, Milleron B, Morin F, Zalcman G, Wislez M.

Rev Mal Respir. 2018 Nov;35(9):983-988. doi: 10.1016/j.rmr.2018.08.006. Epub 2018 Sep 20. French.

2.

[Structuring the French thoracic oncology over the last 20 years].

Milleron B.

Rev Mal Respir. 2017 Nov;34(9):973-975. doi: 10.1016/j.rmr.2017.07.001. Epub 2017 Oct 13. French. No abstract available.

PMID:
29033204
3.

[Current knowledge on perioperative treatments of non-small cell lung carcinomas].

Brosseau S, Naltet C, Nguenang M, Gounant V, Mordant P, Milleron B, Castier Y, Zalcman G.

Rev Mal Respir. 2017 Jun;34(6):618-634. doi: 10.1016/j.rmr.2016.12.001. Epub 2017 Jul 12. Review. French.

PMID:
28709816
4.

[Clinical research activity of the French cancer cooperative network: Overview and perspectives].

Dubois C, Morin F, Moro-Sibilot D, Langlais A, Seitz JF, Girault C, Salles G, Haioun C, Deschaseaux P, Casassus P, Mathiot C, Pujade-Lauraine É, Votan B, Louvet C, Delpeut C, Bardet É, Vintonenko N, Hoang Xuan K, Vo M, Michon J, Milleron B.

Bull Cancer. 2017 Jul - Aug;104(7-8):652-661. doi: 10.1016/j.bulcan.2017.05.006. Epub 2017 Jul 5. French.

PMID:
28688747
5.

Pazopanib or placebo in completely resected stage I NSCLC patients: results of the phase II IFCT-0703 trial.

Besse B, Mazières J, Ribassin-Majed L, Barlesi F, Bennouna J, Gervais R, Moreau L, Berard H, Debieuvre D, Molinier O, Moro-Sibilot D, Souquet PJ, Jacquot S, Petit L, Lena H, Pignon JP, Lacas B, Morin F, Milleron B, Zalcman G, Soria JC; Intergroupe Francophone de Cancérologie Thoracique (IFCT).

Ann Oncol. 2017 May 1;28(5):1078-1083. doi: 10.1093/annonc/mdx070.

PMID:
28327934
6.

[Lung screening].

Milleron B, Gounant V, Khalil A, Couraud S.

Rev Pneumol Clin. 2017 Feb;73(1):27-33. doi: 10.1016/j.pneumo.2016.10.002. Epub 2016 Dec 10. Review. French.

PMID:
27956083
7.

Lung Cancer Screening with Chest Computed Tomography in People Living with HIV: A Review by the Multidisciplinary CANCERVIH Working Group.

Makinson A, Le Moing V, Reynes J, Ferry T, Lavole A, Poizot-Martin I, Pujol JL, Spano JP, Milleron B.

J Thorac Oncol. 2016 Oct;11(10):1644-52. doi: 10.1016/j.jtho.2016.06.026. Epub 2016 Jul 20. Review.

8.

Health-related quality of life in elderly patients with advanced non-small cell lung cancer comparing carboplatin and weekly paclitaxel doublet chemotherapy with monotherapy.

Fiteni F, Anota A, Bonnetain F, Oster JP, Pichon E, Wislez M, Dauba J, Debieuvre D, Souquet PJ, Bigay-Game L, Molinier O, Dansin E, Poudenx M, Milleron B, Morin F, Zalcman G, Quoix E, Westeel V.

Eur Respir J. 2016 Sep;48(3):861-72. doi: 10.1183/13993003.01695-2015. Epub 2016 Jun 23.

9.

Routine molecular profiling of patients with advanced non-small-cell lung cancer: results of a 1-year nationwide programme of the French Cooperative Thoracic Intergroup (IFCT).

Barlesi F, Mazieres J, Merlio JP, Debieuvre D, Mosser J, Lena H, Ouafik L, Besse B, Rouquette I, Westeel V, Escande F, Monnet I, Lemoine A, Veillon R, Blons H, Audigier-Valette C, Bringuier PP, Lamy R, Beau-Faller M, Pujol JL, Sabourin JC, Penault-Llorca F, Denis MG, Lantuejoul S, Morin F, Tran Q, Missy P, Langlais A, Milleron B, Cadranel J, Soria JC, Zalcman G; Biomarkers France contributors.

Lancet. 2016 Apr 2;387(10026):1415-1426. doi: 10.1016/S0140-6736(16)00004-0. Epub 2016 Jan 15.

10.

Bevacizumab for newly diagnosed pleural mesothelioma in the Mesothelioma Avastin Cisplatin Pemetrexed Study (MAPS): a randomised, controlled, open-label, phase 3 trial.

Zalcman G, Mazieres J, Margery J, Greillier L, Audigier-Valette C, Moro-Sibilot D, Molinier O, Corre R, Monnet I, Gounant V, Rivière F, Janicot H, Gervais R, Locher C, Milleron B, Tran Q, Lebitasy MP, Morin F, Creveuil C, Parienti JJ, Scherpereel A; French Cooperative Thoracic Intergroup (IFCT).

Lancet. 2016 Apr 2;387(10026):1405-1414. doi: 10.1016/S0140-6736(15)01238-6. Epub 2015 Dec 21. Erratum in: Lancet. 2016 Apr 2;387(10026):e24.

PMID:
26719230
11.

Prognostic value of health-related quality of life for overall survival in elderly non-small-cell lung cancer patients.

Fiteni F, Vernerey D, Bonnetain F, Vaylet F, Sennélart H, Trédaniel J, Moro-Sibilot D, Herman D, Laizé H, Masson P, Derollez M, Clément-Duchêne C, Milleron B, Morin F, Zalcman G, Quoix E, Westeel V.

Eur J Cancer. 2016 Jan;52:120-8. doi: 10.1016/j.ejca.2015.10.004. Epub 2015 Dec 10.

PMID:
26682871
12.

[Pathological complete response: A predictive survival factor after neoadjuvant chemotherapy in lung cancer].

Milleron B, Westeel V, Gounant V, Wislez M, Quoix E.

Bull Cancer. 2016 Jan;103(1):66-72. doi: 10.1016/j.bulcan.2015.11.001. Epub 2015 Dec 9. Review. French.

PMID:
26682626
13.

[Script concordance test for knowledge assessment of lung cancer screening].

Couraud S, Girard P, Girard N, Souquet PJ, Coiffard B, Charlin B, Milleron B.

Rev Mal Respir. 2016 May;33(5):333-42. doi: 10.1016/j.rmr.2015.09.001. Epub 2015 Oct 23. French.

PMID:
26603957
14.

[Economic impact of lung cancer screening in France: A modeling study].

Gendarme S, Perrot É, Reskot F, Bhoowabul V, Fourre G, Souquet PJ, Milleron B, Couraud S.

Rev Mal Respir. 2017 Sep;34(7):717-728. doi: 10.1016/j.rmr.2015.10.004. Epub 2015 Nov 12. French.

PMID:
26585377
15.

Similar survival rates with first-line gefitinib, gemcitabine, or docetaxel in a randomized phase II trial in elderly patients with advanced non-small cell lung cancer and a poor performance status (IFCT-0301).

Des Guetz G, Landre T, Westeel V, Milleron B, Vaylet F, Urban T, Barlesi F, Souquet PJ, Debieuvre D, Braun D, Fraboulet G, Monnet I, Uzzan B, Molinier O, Morin F, Moro-Sibilot D, Morère JF.

J Geriatr Oncol. 2015 May;6(3):233-40. doi: 10.1016/j.jgo.2015.02.002. Epub 2015 Feb 16.

PMID:
25698450
16.

Perception of lung cancer among the general population and comparison with other cancers.

Mazières J, Pujol JL, Kalampalikis N, Bouvry D, Quoix E, Filleron T, Targowla N, Jodelet D, Milia J, Milleron B.

J Thorac Oncol. 2015 Mar;10(3):420-5. doi: 10.1097/JTO.0000000000000433.

17.

2014 update on non-small cell lung cancer (excluding diagnosis).

Gounant V, Khalil A, Créquit P, Lavole A, Ruppert AM, Antoine M, Milleron B, Wislez M, Carette MF, Assouad J, Cadranel J.

Diagn Interv Imaging. 2014 Jul-Aug;95(7-8):721-5. doi: 10.1016/j.diii.2014.05.004. Epub 2014 Jul 11.

18.

Estimating overdiagnosis in lung cancer screening.

Couraud S, Greillier L, Milleron B; IFCT Lung Cancer Screening Group.

JAMA Intern Med. 2014 Jul;174(7):1197. doi: 10.1001/jamainternmed.2014.1532. No abstract available.

PMID:
25003882
19.

[Second medical opinions in the era of multidisciplinary coordination meetings].

Milleron B, Gounant V.

Rev Mal Respir. 2014 May;31(5):394-5. doi: 10.1016/j.rmr.2014.05.001. French. No abstract available.

PMID:
24878154
20.

[Individual lung cancer screening in practice. Perspectives on the propositions from the multidisciplinary group of the Intergroupe francophone de cancérologie thoracique, the Société d'imagerie thoracique and the Groupe d'oncologie de langue française].

Girard N, Gounant V, Mennecier B, Greillier L, Cortot AB, Couraud S, Besse B, Brouchet L, Castelnau O, Ferretti GR, Frappé P, Khalil A, Lefebure P, Laurent F, Liebart S, Margery J, Molinier O, Quoix E, Revel MP, Stach B, Souquet PJ, Thomas P, Trédaniel J, Lemarié E, Zalcman G, Barlési F, Milleron B; groupe de travail multidisciplinaire de l’Intergroupe francophone de cancérologie thoracique, de la Société d’imagerie thoracique et du Groupe d’oncologie de langue française.

Rev Mal Respir. 2014 Jan;31(1):91-103. doi: 10.1016/j.rmr.2013.10.641. Epub 2014 Jan 10. French. No abstract available.

PMID:
24461451
21.

Reply to letter.

Westeel V, Quoix E, Zalcman G, Milleron B.

Eur J Cancer. 2014 Feb;50(3):678. doi: 10.1016/j.ejca.2013.11.019. Epub 2013 Dec 10. No abstract available.

PMID:
24331956
22.

Second-line therapy in elderly patients with advanced nonsmall cell lung cancer.

Quoix E, Westeel V, Moreau L, Pichon E, Lavolé A, Dauba J, Debieuvre D, Souquet PJ, Bigay-Game L, Dansin E, Poudenx M, Molinier O, Vaylet F, Moro-Sibilot D, Herman D, Sennelart H, Tredaniel J, Mennecier B, Morin F, Baudrin L, Milleron B, Zalcman G; Intergroupe Francophone de Cancérologie Thoracique.

Eur Respir J. 2014 Jan;43(1):240-9. doi: 10.1183/09031936.00048213. Epub 2013 Oct 10.

23.

Management strategy of pulmonary nodule in 2013.

Lederlin M, Revel MP, Khalil A, Ferretti G, Milleron B, Laurent F.

Diagn Interv Imaging. 2013 Nov;94(11):1081-94. doi: 10.1016/j.diii.2013.05.007. Epub 2013 Sep 12. Review.

24.

[Lung cancer in never smokers: a French national cohort (BioCAST/IFCT-1002)].

Couraud S, Labonne S, Missy P, Morin F, Tran Q, Deroy A, Milleron B, Blanché H, Zalcman G, Souquet PJ; les membres du Groupe de travail « non-fumeurs de l’IFCT ».

Rev Mal Respir. 2013 Sep;30(7):576-83. doi: 10.1016/j.rmr.2013.03.006. Epub 2013 May 18. French.

PMID:
24034464
25.

A randomised trial comparing preoperative to perioperative chemotherapy in early-stage non-small-cell lung cancer (IFCT 0002 trial).

Westeel V, Quoix E, Puyraveau M, Lavolé A, Braun D, Laporte S, Bigay-Game L, Pujol JL, Ozenne G, Rivière A, Douillard JY, Lebeau B, Debieuvre D, Poudenx M, David P, Molinier O, Zalcman G, Lemarié E, Morin F, Depierre A, Milleron B; Intergroupe Francophone de Cancérologie Thoracique.

Eur J Cancer. 2013 Aug;49(12):2654-64. doi: 10.1016/j.ejca.2013.04.013. Epub 2013 Jun 1.

PMID:
23735703
26.

[From the NLST randomized trial to the clinic: how should we implement individual lung cancer screening in clinical practice?].

Couraud S, Barlési F, Lemarié E, Zalcman G, Milleron B; pour le groupe de travail IFCT/GOLF sur le dépistage du cancer broncho-pulmonaire.

Rev Mal Respir. 2013 Jan;30(1):15-7. doi: 10.1016/j.rmr.2012.10.021. Epub 2012 Nov 22. French. No abstract available.

PMID:
23318184
27.

Clinical and molecular features in patients with advanced non-small-cell lung carcinoma refractory to first-line platinum-based chemotherapy.

Giroux Leprieur E, Antoine M, Vieira T, Duruisseaux M, Poulot V, Rabbe N, Belmont L, Gounant V, Lavolé A, Milleron B, Lacave R, Cadranel J, Wislez M.

Lung Cancer. 2013 Feb;79(2):167-72. doi: 10.1016/j.lungcan.2012.10.010. Epub 2012 Nov 13.

PMID:
23153658
28.

[CT screening for lung cancer].

Gounant V, Assouad J, Lavolé A, Wislez M, Cadranel J, Milleron B.

Bull Cancer. 2012 Nov;99(11):1039-44. doi: 10.1684/bdc.2012.1658. Review. French.

29.

From randomized trials to the clinic: is it time to implement individual lung-cancer screening in clinical practice? A multidisciplinary statement from French experts on behalf of the French intergroup (IFCT) and the groupe d'Oncologie de langue francaise (GOLF).

Couraud S, Cortot AB, Greillier L, Gounant V, Mennecier B, Girard N, Besse B, Brouchet L, Castelnau O, Frappé P, Ferretti GR, Guittet L, Khalil A, Lefebure P, Laurent F, Liebart S, Molinier O, Quoix E, Revel MP, Stach B, Souquet PJ, Thomas P, Trédaniel J, Lemarié E, Zalcman G, Barlési F, Milleron B; French lung cancer screening statement taskforce; groupe d'Oncologie de langue française.

Ann Oncol. 2013 Mar;24(3):586-97. doi: 10.1093/annonc/mds476. Epub 2012 Nov 7.

30.

Randomized, phase III study of gemcitabine or erlotinib maintenance therapy versus observation, with predefined second-line treatment, after cisplatin-gemcitabine induction chemotherapy in advanced non-small-cell lung cancer.

Pérol M, Chouaid C, Pérol D, Barlési F, Gervais R, Westeel V, Crequit J, Léna H, Vergnenègre A, Zalcman G, Monnet I, Le Caer H, Fournel P, Falchero L, Poudenx M, Vaylet F, Ségura-Ferlay C, Devouassoux-Shisheboran M, Taron M, Milleron B.

J Clin Oncol. 2012 Oct 1;30(28):3516-24. Epub 2012 Sep 4.

PMID:
22949150
31.

Pathologic complete response to preoperative chemotherapy predicts cure in early-stage non-small-cell lung cancer: combined analysis of two IFCT randomized trials.

Mouillet G, Monnet E, Milleron B, Puyraveau M, Quoix E, David P, Ducoloné A, Molinier O, Zalcman G, Depierre A, Westeel V; Intergroupe Francophone de Cancérologie Thoracique (IFCT).

J Thorac Oncol. 2012 May;7(5):841-9. doi: 10.1097/JTO.0b013e31824c7d92.

32.

Lung cancer in never smokers--a review.

Couraud S, Zalcman G, Milleron B, Morin F, Souquet PJ.

Eur J Cancer. 2012 Jun;48(9):1299-311. doi: 10.1016/j.ejca.2012.03.007. Epub 2012 Mar 28. Review.

PMID:
22464348
33.

Routine administration of a single dose of cisplatin ≥ 75 mg/m2 after short hydration in an outpatient lung-cancer clinic.

Lavolé A, Danel S, Baudrin L, Gounant V, Ruppert AM, Epaud C, Belmont L, Rosencher L, Cadranel J, Milleron B.

Bull Cancer. 2012 Apr 1;99(4):E43-8. doi: 10.1684/bdc.2012.1555.

34.

An apoptosis methylation prognostic signature for early lung cancer in the IFCT-0002 trial.

de Fraipont F, Levallet G, Creveuil C, Bergot E, Beau-Faller M, Mounawar M, Richard N, Antoine M, Rouquette I, Favrot MC, Debieuvre D, Braun D, Westeel V, Quoix E, Brambilla E, Hainaut P, Moro-Sibilot D, Morin F, Milleron B, Zalcman G; Intergroupe Francophone de Cancérologie Thoracique.

Clin Cancer Res. 2012 May 15;18(10):2976-86. doi: 10.1158/1078-0432.CCR-11-2797. Epub 2012 Mar 20.

35.

[Neurologic paraneoplastic syndrome with anti-CV2/CRMP5 antibodies revealing a small cell lung cancer. Effectiveness of the lung cancer treatment].

Rosencher L, Maisonobe T, Lavole A, Milleron B, Ferroir JP.

Rev Neurol (Paris). 2012 Apr;168(4):371-4. doi: 10.1016/j.neurol.2011.07.016. Epub 2012 Mar 3. French.

PMID:
22387203
36.

Factors associated with long-term survival of patients with advanced non-small cell lung cancer.

Giroux Leprieur E, Lavole A, Ruppert AM, Gounant V, Wislez M, Cadranel J, Milleron B.

Respirology. 2012 Jan;17(1):134-42. doi: 10.1111/j.1440-1843.2011.02070.x.

PMID:
21943088
37.

Chemotherapy in elderly patients with advanced non-small cell lung cancer.

Quoix E, Westeel V, Zalcman G, Milleron B.

Lung Cancer. 2011 Dec;74(3):364-8. doi: 10.1016/j.lungcan.2011.06.006. Epub 2011 Sep 3. Review.

PMID:
21893363
38.

Skin toxicities compromise prolonged pemetrexed treatment.

Eguia B, Ruppert AM, Fillon J, Lavolé A, Gounant V, Epaud C, Milleron B, Moguelet P, Wislez M, Frances C, Cadranel J.

J Thorac Oncol. 2011 Dec;6(12):2083-9. doi: 10.1097/JTO.0b013e31822e722f.

39.

Carboplatin and weekly paclitaxel doublet chemotherapy compared with monotherapy in elderly patients with advanced non-small-cell lung cancer: IFCT-0501 randomised, phase 3 trial.

Quoix E, Zalcman G, Oster JP, Westeel V, Pichon E, Lavolé A, Dauba J, Debieuvre D, Souquet PJ, Bigay-Game L, Dansin E, Poudenx M, Molinier O, Vaylet F, Moro-Sibilot D, Herman D, Bennouna J, Tredaniel J, Ducoloné A, Lebitasy MP, Baudrin L, Laporte S, Milleron B; Intergroupe Francophone de Cancérologie Thoracique.

Lancet. 2011 Sep 17;378(9796):1079-88. doi: 10.1016/S0140-6736(11)60780-0. Epub 2011 Aug 8.

PMID:
21831418
40.

[Editorial. NSCLC and personalized medicine: yesterday, today and tomorrow].

Milleron B.

Rev Pneumol Clin. 2011 Jun;67 Suppl 1:S1-2. doi: 10.1016/S0761-8417(11)70001-3. French. No abstract available.

PMID:
21777760
41.

Coexisting pulmonary nodules in operable lung cancer: prevalence and probability of malignancy.

Ruppert AM, Lerolle U, Carette MF, Lavole A, Khalil A, Bazelly B, Antoine M, Cadranel J, Milleron B.

Lung Cancer. 2011 Nov;74(2):233-8. doi: 10.1016/j.lungcan.2011.03.012. Epub 2011 Apr 20.

PMID:
21511355
42.

[Non-small cell lung carcinoma: Perspectives for the twenty-first century?].

Milleron B.

Presse Med. 2011 Apr;40(4 Pt 1):368-70. doi: 10.1016/j.lpm.2011.01.025. Epub 2011 Mar 8. French. No abstract available.

PMID:
21388779
43.

[A phase II study of cetuximab, pemetrexed, cisplatin, and concurrent radiotherapy in patients with locally advanced, unresectable, stage III, non squamous, non-small cell lung cancer (NSCLC)].

Tredaniel J, Mornex F, Barillot I, Diaz O, Hennequin C, Le Pechoux C, Lavole A, Giraud P, Souquet PJ, Teixeira L, Vaylet F, Zalcman G, Baudrin L, Morin F, Milleron B.

Rev Mal Respir. 2011 Jan;28(1):51-7. doi: 10.1016/j.rmr.2010.06.027. Epub 2011 Jan 11. French.

PMID:
21277474
44.

[Impact of positron emission tomography on clinical management of potentially resectable non-small-cell lung cancer: a French prospective multicenter study].

Margery J, Milleron B, Vaylet F, Grahek D, Lebeau B, Mangiapan G, Bonardel G, de Labriolle-Vaylet C, Meignan M, Carette MF, Talbot JN, Housset B.

Rev Pneumol Clin. 2010 Oct;66(5):313-20. doi: 10.1016/j.pneumo.2010.07.015. Epub 2010 Sep 15. French.

PMID:
21087727
45.

[Pulmonary fibrosis and arterial hypertension revealing a chronic pulmonary schistosomiasis. An unusual diagnosis in Europe].

Ngampolo I, Billhot M, Niang A, Epaud C, Riviere F, Le Floch H, Vaylet F, Milleron B, Margery J.

Rev Pneumol Clin. 2010 Oct;66(5):326-9. doi: 10.1016/j.pneumo.2010.07.006. Epub 2010 Sep 6. French.

PMID:
21087729
46.

Miliary brain metastases in lung cancer.

Ruppert AM, Stankoff B, Lavolé A, Gounant V, Milleron B, Seilhean D.

J Clin Oncol. 2010 Dec 1;28(34):e714-6. doi: 10.1200/JCO.2009.27.0140. Epub 2010 Sep 7. No abstract available.

PMID:
20823412
47.

[Management and outcome of French elderly patients with lung cancer: an IFCT survey].

Quoix E, Monnet I, Scheid P, Hamadouche A, Chouaid C, Massard G, Depierre A, Souquet PJ, Braun D, Girard P, Breton JL, Lebitasy MP, Milleron B; l'Intergroupe francophone de cancérologie thoracique (IFCT).

Rev Mal Respir. 2010 May;27(5):421-30. doi: 10.1016/j.rmr.2010.02.013. Epub 2010 Mar 25. French.

PMID:
20569874
48.

[Pulmonary oncology discussions].

Milleron B, Quoix E.

Rev Pneumol Clin. 2010 Apr;66(2 Suppl 1):H1. doi: 10.1016/S0761-8417(10)70001-8. French. No abstract available.

PMID:
20488335
49.

Randomized phase II trial of gefitinib or gemcitabine or docetaxel chemotherapy in patients with advanced non-small-cell lung cancer and a performance status of 2 or 3 (IFCT-0301 study).

Morère JF, Bréchot JM, Westeel V, Gounant V, Lebeau B, Vaylet F, Barlési F, Urban T, Souquet PJ, Debieuvre D, Baudrin L, Zalcman G, Morin F, Milleron B, Moro-Sibilot D.

Lung Cancer. 2010 Dec;70(3):301-7. doi: 10.1016/j.lungcan.2010.03.003. Epub 2010 Apr 18.

PMID:
20400201
50.

Osteoblastic reaction in non-small cell lung carcinoma and its association to epidermal growth factor receptor tyrosine kinase inhibitors response and prolonged survival.

Pluquet E, Cadranel J, Legendre A, Faller MB, Souquet PJ, Zalcman G, Perol M, Fraboulet G, Oliveiro G, De Fraipont F, Quoix E, Lantuejoul S, Milleron B, Moro-Sibilot D.

J Thorac Oncol. 2010 Apr;5(4):491-6. doi: 10.1097/JTO.0b013e3181cf0440.

Supplemental Content

Loading ...
Support Center